Immunomodulatory Effects of Aerobic Training in Obesity by Nickel, Thomas et al.
Hindawi Publishing Corporation
Mediators of Inﬂammation
Volume 2011, Article ID 308965, 10 pages
doi:10.1155/2011/308965
Research Article
ImmunomodulatoryEffectsof Aerobic Trainingin Obesity
Thomas Nickel,1 Henner Hanssen,2 IngridEmslander,2 Verena Drexel,2 GernotHertel,2
Arno Schmidt-Trucks¨ ass,3 Claudia Summo,1 Zeljka Sisic,1 Marius Lambert,1 Eva Hoster,4
Martin Halle,2 andMichaelWeis1
1Medizinische Klinik und Poliklinik I, Campus Grosshadern, Ludwig-Maximilians-Universit¨ at M¨ unchen,
Marchioninistr.15, 81377 Munich, Germany
2Department of Prevention and Sports Medicine, Technische Universit¨ at M¨ unchen, Klinikum rechts der Isar (MRI),
80809 Munich, Germany
3Sports Medicine, Institute of Exercise and Health Sciences, University Basel, 4003 Basel, Switzerland
4Institute for Medical Informatics Biometry and Epidemiology, Ludwig-Maximilians-Universit¨ at M¨ unchen, 81377 Munich, Germany
Correspondence should be addressed to Thomas Nickel, tsnickel@web.de
Received 3 August 2010; Revised 24 November 2010; Accepted 3 January 2011
Academic Editor: Natalija Novak
Copyright © 2011 Thomas Nickel et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction. Physical inactivity and obesity are independent risk factors for atherosclerosis. We analyzed the immunomodulatory
capacity of 10-week intensiﬁed exercise training (ET) in obese and lean athletes. Markers of the innate immune response were
investigated in obese (ONE: ET≤40km/week) and lean athletes (LNE: ET≤40km/week and LE: ET≥55km/week). Methods.
Circulating dendritic cells (DC) were analyzed by ﬂow-cytometry for BDCA-1/-2-expression. TLR-2/-4/-7 and MyD88 were
analyzed by RT-PCR and Western blot. Circulating oxLDL levels were analyzed by ELISA. Results. BDCA-1 expression at baseline
was lower in ONE compared to both other groups (ONE 0.15%; LNE 0.27%; LE 0.33%; P<. 05), but signiﬁcantly increased in
ONE after training (+50%; P<. 05). In contrast, BDCA-2 expression at baseline was higher in ONE (ONE 0.25%; LNE 0.11%; LE
0.09%; P<. 05) and decreased in ONE after the 10-week training period (−27%; P<. 05). Gene activations of TLR-4 and TLR-7
with corresponding protein increase were found for all three groups (P<. 01/P<. 05) compared to pre training. A reduction of
oxLDL levels was seen in ONE (−61%; P<. 05). Conclusions. Intensiﬁed exercise induces an increase of BDCA-1+ DCs and TLR-
4/-7 in obese athletes. We hereby describe new immune modulatory eﬀects, which—through regular aerobic exercise—modulate
innate immunity and pro-inﬂammatory cytokines in obesity.
1.Introduction
Atherosclerosis is a chronic, smoldering immune-mediated
disease. Environmental factors, including diet and physical
activity, play a central role for the balance of a normal
immune homeostasis [1]. Physical activity is associated
with a reduced risk of cardiovascular disease, cardiovascular
death, and total mortality (−30–45%) in men [2]. Beside
these cardiovascular eﬀects, also incidence, mortality, and
relapse of cancer are reduced by regular activity [3].
Obesity, an ubiquitous disease, is associated with
increased cardiovascular events as well as a higher incidence
of neoplasms [4, 5]. Obese subjects suﬀer from subclinical
inﬂammation, which has been suggested to induce for exam-
ple insulin resistance and metabolic syndrome [6]. Obesity is
associated with increased plasma levels of proinﬂammatory
cytokinessuchasTNF-αandIL-6[7].Moreover,adiponectin
levels are inversely correlated with the grade of obesity and
also with the risk of colon cancer [8] but also adiponectin
levels increase by exercise [9].
These immunomodulatory changes found in obesity
could also aﬀect the defence capacity of the immune system
making obese subjects more susceptible to infection [10].
Current research eﬀorts are being made to address the exist-
ing relationship between obesity and immunocompetence
and its impact on the long-term development of cardio-
vascular diseases [11].
The beneﬁcial eﬀects of physical activity-induced
reduced cardiovascular risk are, in part, mediated by an
exercise-induced amelioration of inﬂammation [7, 12].2 Mediators of Inﬂammation
Cross- sectional and longitudinal studies on the coherence
of exercise and the immune response demonstrate long-term
anti-inﬂammatory eﬀects [7, 12, 13].
Dendritic cells (DCs) are on one hand crucial mediators
of the innate immune response and represent on the other
hand a link to the adaptive immune system. DCs are
omnipresent, highly potent antigen presenting cells, and
able to prime naive T-cells [14, 15]. BDCA-1+ DCs (DC-1)
trigger a Th-1- and BDCA-2+ DCs (DC-2) a Th-2-immune-
response [16–18].
Toll-like receptors (TLRs), which are expressed on diﬀer-
enttypesofimmune-cells,arecrucialmediatorsoftheinnate
immune response [19]. The most important adapter protein
for TLRs is MyD88 which activates the transcription factor
NF-κB[ 20].
Relatively little is known about the impact of exercise on
DC-diﬀerentiation and for TLR-expression even if they take
up an important pace in initiation and modulation of the
immune defense [15, 21].
In this study, we analyzed the immunomodulatory
capacity of a 10-week exercise program, focusing on TLR-
expression, DC-diﬀerentiation, and systemic inﬂammatory
markers. We tested the hypothesis, whether regular exercise
training aﬀects DC-diﬀerentiation and TLR-expression dif-
ferently in obese verses lean runners with diﬀerent levels of
cardiovascular ﬁtness.
2. Methods
2.1. Subjects. Sixty amateur marathon runners intending to
participate in the 2007 Munich marathon were recruited
by a study appeal in a local newspaper and by written
invitations sent to local running clubs. The study was
approved by the hospital’s ethics committee of the Technical
University of Munich. Recruitment was limited to healthy
male marathon runners aged 30–60 years who had run at
least a half-marathon in the previous 3 years and who had no
cardiovascular risk factor other than obesity. The candidates
volunteered for an individual tailored, supervised training
program. All athletes gave written informed consent. The
sample size was restricted to sixty subjects in order to ensure
optimal individual supervised exercise training over a time
period of 10 weeks.
2.2. Study Design and Exercise Training Protocol. The study
was approved by the hospital’s ethics committee of the
Technical University of Munich. Exclusion criteria consisted
of known coronary or structural heart disease, insulin-
dependent diabetes mellitus, drug treatment for type 2
diabetes or hypertension, hyperlipoproteinemia, renal dys-
function, chronic inﬂammatory, and musculoskeletal dis-
order. Subjects were divided into two age-matched groups
depending on the extensiveness of training: ONE and LNE
were scheduled for ≤40 km/week and LE was scheduled for
≥55km/week. Premarathon exercise training in ONE and
LNE was only sporadic, whereas LE was characterized by
continuous steady state training throughout the year.
Within the ﬁrst group of non-elite runners, subjects
were divided into obese (body mass index [BMI] ≥30kg/m2
and waist circumference [WC] ≥102cm) and nonobese
participants. A medical history, a general questionnaire, and
a physical examination, including determination of body fat
composition (caliper measurement), standardized routine
blood pressure measurements, and fasting (overnight) blood
samples,wereobtained2–5daysbeforeandafterthetraining
program. All participants fasted before the blood draws and
acute bouts of exercise were avoided 2 days prior to the
examination. Anthropometry was performed by a single
experienced examiner.
Participants took part in a 10-week endurance developed
by sports scientists according to the current guidelines [22].
The exercise program of all groups consisted of continuous
aerobic exercise and interval training including concomitant
warm-up and cool-down periods with a gradual increase
in duration and intensity during the course of the 10-week
training program. Before the start of the training program,
each athlete performed a symptom-limited treadmill ergom-
etry (6km/h, increase by 1km/h every 3min) to determine
theindividualanaerobicthreshold(IAT),allowingindividual
classiﬁcation of training intensity and ﬁtness levels. Accord-
ingly, an individual training program for each participant
was prescribed with regard to current ﬁtness levels. The
intensity of the training was given by individual target
heartrates.Participantsusedheartratemonitors.Supervised
exercise training by sports scientists was oﬀered four times a
week under medical supervision. Training was documented
with respect to intensity, duration, and kilometres run per
week by a written protocol. After the 10-week training
program, the treadmill ergometry was repeated in order to
quantify the improvement of the individual ﬁtness level.
2.3.Flow-CytometerAnalysisofPeripheralBloodMononuclear
Cells. Donor blood was prepared as described before [23].
Antibodies were matched with iso-type-controls (Mouse-
γ2a-(FITC)/-γ1(PE)-FastImmune; BD; USA). A total of
250.000 events were acquired and analyzed using Cellquest
(BD, Belgium) [23]. For determining subpopulations of
DCs we analyzed BDCA-1/2 expression (Miltenyibiotec,
Germany) following the protocol of Narbutt et al. [24]
2.4. Total RNA Isolation and Real-Time PCR. TLR-2/-4/-7
and MyD88 expression were analyzed using RT-PCR. mRNA
isolation and cDNA synthesis were performed according
to the instructions provided by the manufacturer and
based on our previous publication [23]. The quantitative
RT-PCR system provides optimal performance with SYBR
Green primers (Qiagen, Germany). RT-PCR was performed
in the ABI PRISMTM 7700 System (Applied Biosystems,
Germany). Data analysis was performed using the delta-
delta ct method [23, 25]. The diﬀerent primer sequences
(MWG-Biotech AG, Germany) of the analyzed receptors are
as follow.
GAPDH:15
 -CGGAGTCAACGGATTTGGTCGTAT-
3
 ;25
 - AGC CTT CTC CAT GGT GGT GAA GAC-3
 ; TLR-
2: 15
 - CCA CTT GCC AGG AAT GAA GT-3
 ;25
 -G A T
GCC TAC TGG GTG GAG AA-5
 ; TLR-4: 15
 -T C CA T A
AAA GCC GAA AGG TG-3
 ;25
 - GAT ACC AGC ACG ACTMediators of Inﬂammation 3
GCT CA-3
 ; TLR-7: 15
 -TTA CCT GGA TGG AAA CCA
GCT ACT-3
 ;25
 -TCA AGG CTG AGA AGC TGT AAG
CTA-3
 ; MyD88: 15
 -GCA CAT GGG CAC ATA CAG AC-3
 ;
25
 -GAC ATG GTT AGG CTC CCT CA-3
 ; NFκB: 15
 -TGG
AGT CTG GGA AGG ATT TG-3
 ;25
 - CGA AGC TGG ACA
AAC ACA GA-3
 .
2.5. Western Blot. PBMCs were isolated and their protein
extracted according to the instructions provided by the
manufacturer and based on our previous publication [15].
The anti-MyD88 (mouse) (Santa Cruz, USA) was diluted
1:200, the anti-TLR-2 (mouse) (IMGENEX, USA) was
diluted 1:500, the anti-TLR-4 (mouse) (IMGENEX, USA)
1:150, and the anti-TLR-7 (rabbit) (IMGENEX, USA)
1:150, respectively. All antibodies were incubated at 4◦C
overnight. Beta actin (goat) (1:500, Santa Cruz, USA) was
used as the internal standard to ensure that equal amounts of
protein were loaded.
The antigen-antibody complex was visualized using anti-
mouse HRP 1:2500 (Santa Cruz, USA) for MyD88, TLR-
2 and TLR-4, anti-rabbit HRP 1:1000 (Santa Cruz, USA)
for TLR-7, and anti-goat HRP 1:5000 (Santa Cruz, USA)
for beta actin. An enhanced chemiluminescence detection
system (ECL-Pierce, Invitrogen; USA) was developed using
the X-Omat (Kodak; USA). Quantitative analysis of Western
blots by densitometry was carried out using the histogram
function in Photoshop 7.0 software. All values were nor-
malised to the beta actin loading control.
2.6. Plasma Concentration of oxLDL, Adiponectin, IL-6, and
TNF-α by ELISA. Plasma tubes were centrifuged and the
plasma was fractionated and frozen at −80◦C. Samples
were defrosted and oxLDL, adiponectin, IL-6, and TNF-
α levels were examined by using cytokine-speciﬁc ELISA
kit according to the manufacturers’ instructions (oxLDL:
Immunoteck, Germany; adiponektin: RayBio, USA; IL-6:
Bender Med-Systems, Austria; TNF-α:B i o s o u r c e ,U S A ) .
The probes were distributed in duplicates on the plates
and intra-assay and interassay coeﬃcients of variation
were ≤10%.
2.7. Statistical Analysis. Data are presented as mean +/−
standard-deviation of the mean (SDM) and by boxplots
representing the interquartile range (25th to 75th percentile)
aroundthemedian(darklineineachbox).TheKolmogorov-
Smirnov test was used to determine whether or not the
data were normally distributed. Data that were not normally
distributed were analyzed using the Wilcoxon signed Rank
Test for paired samples. Diﬀerences between values before
and after training were compared between the three groups
bymeansoftheKruskal-Wallistest.Adoptingaclosedtesting
procedure, only if the Kruskal-Wallis test was signiﬁcant,
pairwise comparisons were added post-hoc using the Mann-
Whitney U test. Diﬀerences between means were considered
signiﬁcant with P<. 05 and highly signiﬁcant with P<
.01. SPSS (Version 16, IBM-USA) was used for statistical
analysis.
3. Results
3.1. Study Group. From the originally recruited 20 probands
per group, 15 in the obese-non-elite (ONE) group and
16 in the lean-non-elite (LNE) and lean-elite (LE) group
completed the 10-week training program. Drop out reasons
were muscular injuries and respiratory tract infections.
Average training mileage was 35±8km/week in ONE, 38 ±
1km/week in LNE, and 54±2km/week in LE during the 10
weeks of the training program. The diﬀerence in distance
between ONE/LNE and LE was signiﬁcant (P<. 01).
Participants in all three groups showed a reduction in
t o t a lb o d yw e i g h t( O N E−1.4kg, LNE −1.1kg and LE
−1.7kg; P<. 05) and corresponding BMI (Table 1). In
ONE and LE, weight loss reﬂected a decrease of the waist
circumference (ONE −2.8cm; LE −1.9cm; P<. 05). A
signiﬁcant reduction in total body fat was only found in LNE
(P<. 01) and LE (P<. 05). Body fat reduction in obese
subjects failed to reach signiﬁcance (P = .058) (Table 1).
At baseline, individual anaerobic threshold (IAT) was
lowest in ONE (10.6±0.8) compared to LNE (11.6±0.9)
and LE (13.6±1.4). Exercise training resulted in a signiﬁcant
i m p r o v e m e n to fp h y s i c a lﬁ t n e s s( I A T )i na l lg r o u p s ,w h i c h
was most pronounced in ONE (P<. 01) (Table 1).
We also analyzed the changes of leukocytes, monocytes,
and platelets between before and after the training. There
were no signiﬁcant changes in leucocytes or monocytes, we
only found a signiﬁcant change for the thrombocytes in
response to exercise. Thrombocytes increased by 8000/mm3,
whichwethinkisnotaphysiologicrelevantﬁnding(datanot
shown).
3.2.Flow-CytometerAnalysisofPeripheralBloodMononuclear
Cells. BDCA-1/-2 positive cells represent approximately 1%
of the circulating leucocytes. Circulating BDCA-1+ DCs
are reduced in cerebral- and myocardial-infarction and are
associated with increased occurrence of infections [17, 18].
Myeloid DCs (BDCA-1+) at baseline were reduced
in ONE compared to lean subjects. At baseline, BDCA-
1 expression was 0.15% in the ONE (P<. 05 versus
LNE/NE) and increased to 0.30% (+100%; P<. 05) after the
training period. Exercise training had no signiﬁcant eﬀects
on BDCA-1 expression in LNE and LE (LNE 0.27%/0.26%;
LE 0.33%/0.35%) (Figure 1(a)).
The median diﬀerence of BDCA1-levels before and after
training was signiﬁcantly diﬀerent between the three groups
(P = .039). This eﬀect was mainly seen between LNE and
ONE (−0.05% versus +0.17%, P = .006, supplementary
Table I available on line at doi: 10.1155/2011/308965).
Plasmacytoid DCs (BDCA-2+) at baseline were signif-
icantly higher in ONE compared to LE and LNE. There
was no signiﬁcant diﬀerence between LNE (0.11%) and LE
(0.09%). After the training program, BDCA-2 expression in
ONE decreased signiﬁcantly (−61 %; P<. 05) and reached
the levels of LNE (0.12%) and LE (0.09%), which remained
unchanged after the exercise intervention (Figure 1(b)).
There were no signiﬁcantly diﬀerent eﬀects among the
three groups (P = .117, supplementary Table II available on
line at doi: 10.1155/2011/308965).4 Mediators of Inﬂammation
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(b) Analysis of BDCA-2 expression in PBMCs (FACS)
Figure 1: Representative FACS scans in PBMC expressing of BDCA-1 (a) and BDCA-2 (b) in LE, LNE, and ONE at baseline and after
training. Data presented state the expression of the corresponding receptors in percent. Statistical analysis of the diﬀerent timepoints (intra
group analysis) was performed using the Wilcoxon Test; the comparison of the diﬀerent groups with each other (inter group analysis) was
done by using the Mann-Whitney U Test (∗P<. 05; n = 15/16/16).6 Mediators of Inﬂammation
3.3. RT-PCR for Toll-Like-Receptors (TLRs). TLRs recognize
so-called pathogen associated molecular patterns (PAMPs)
and thereby activate immune pathways. TLRs have an
essential role in the innate immune recognition of microor-
ganisms.
TLR2 recognizes components from a variety of microbial
pathogens. These include lipoproteins from pathogens such
as Gram-negative bacteria [19, 20].
T L R - 2 :A tb a s e l i n e ,n od i ﬀerence in TLR-2 was found
within the groups (data not shown). Gene-expression
increased signiﬁcantly in response to exercise in LNE (1.7-
fold increase; P<. 05). TLR-2 showed similar patterns in
the other groups without reaching signiﬁcance (LE 2.3-fold
increase; ONE 0.9-fold increase) (Figure 2(a)).
TLR4 is essential for the signalling of LPS, with is a
major component of the outer membrane of Gram-negative
bacteria [19, 20].
TLR-4: TLR-4 at baseline did not diﬀer within the groups
(data not shown). TLR-4 was signiﬁcantly upregulated in all
three groups in response to exercise. The diﬀerences were
most pronounced in LE (increase more than 10-fold; P<
.01). TLR-4 increase was 9.6 fold in LNE (P<. 05) and 14
fold in ONE (P<. 05) (Figure 2(b)).
TLR7hasbeenshowntorecognizethesingle-strandRNA
and double-strand RNA of virus-origin such like inﬂuenza
viruses or Respiratory syncytial viruses [19, 20].
TLR-7: TLR-7 at baseline did not diﬀer within the
groups (data not shown). All three groups showed a highly
signiﬁcant exercise-induced upregulation of TLR-7 (LE:
14.9-fold increase; LNE: 22-fold increase; ONE: 6.3-fold
increase; all P<. 01) (Figure 2(c)).
MyD88isauniversaladapterproteinasitisusedbyTLR-
2,-4, and -7 to activate the transcription factor NF-κB[ 20].
ForTLR-2,-4,and-7,therewerenosigniﬁcantlydiﬀerent
eﬀects among the three groups (P = .450, P = .712, and
P = .235, supplementary Table III available on line at doi:
10.1155/2011/308965).
MyD88: MyD88 at baseline did not diﬀer within the
groups (data not shown). All three groups showed no signif-
icant exercise-induced changes in MyD88 gene-expression.
(LE: 2.7±1.47-fold increase; LNE: 2.21± 0.92-fold increase;
ONE: 2.11±0.79 fold increase; n.s.) (data not shown).
NFκB: NFκB at baseline did not diﬀer within the groups
(data not shown). All three groups showed no signiﬁcant
exercise-induced changes in NFκB gene expression. (LE:
1.28±0.36-fold increase; LNE: 1.71±0.41-fold increase;
ONE: 1.43±0.5-fold increase; all P<. 01) (data not shown)
[23].
3.4. Western Blot. To demonstrate a relationship between
gene activation and protein expression, we performed West-
ern blot analysis for TLR-2/-4/-7 and MyD88representative
for 8 probands of the LNE (Figures 2(d)–2(h))g r o u p .F o r
TLR-4 and TLR-7, we found a signiﬁcant increase (+22.6/
+63.3%) in protein expression (both P<. 05). No changes in
protein expression were found for TLR-2, and MyD88.
3.5.ELISAforoxLDL,Adiponectin,IL-6-,andTNF-α. oxLDL
is a principal form of cholesterol that accumulates in
atherosclerotic lesions or plaques. Its levels are generally
considered to be associated with an increased atherosclerotic
burden. At baseline, circulating oxLDL levels were signiﬁ-
cantly higher in ONE (90ng/mL; P<. 05) compared to LE
(77ng/mL). After exercise training, oxLDL levels decreased
by –27% (66ng/mL; P<. 05) in ONE. In contrast to this
ﬁnding, we found an increase in oxLDL after training in
LE (273ng/mL; P<. 05) and LNE (186ng/mL), the latter
did not reach signiﬁcance (Table 1). The median diﬀerence
before and after training was signiﬁcantly diﬀerent between
the three groups (P = .001). This eﬀect was mainly seen
between LNE and ONE (+41ng/mL versus −35ng/mL,
P = .009) and between LE and ONE (+98ng/mL versus
−35ng/mL, P = .001, supplementary Table III available on
line at doi: 10.1155/2011/308965).
At baseline, adiponectin levels were highest in LE
(7642ng/mL), followed by LNE (5972ng/ml) and lowest in
ONE (5459ng/mL). The diﬀerence between LE and ONE
was signiﬁcant (P<. 05). Exercise training induced an
increase of adiponectin serum levels in all groups (LE
8220ng/mL; LNE 7713ng/mL; ONE 5964ng/mL), reaching
signiﬁcance in LNE only (P<. 05) (Table 1). There were
no signiﬁcantly diﬀerent eﬀects among the three groups
(P = .335, supplementary Table III available on line at doi:
10.1155/2011/308965).
IL-6 is secreted by T-cells and macrophages. It stimulates
the immune response and is released by skeletal muscles in
response to endurance exercise. The ELISA-based analysis of
IL-6 atbaseline detected the lowest levels in LE (0.72pg/mL).
In comparison, IL-6 concentrations of LNE and ONE were
signiﬁcantly higher (1.43pg/mL and 1.24pg/mL resp.; P<
.01). Training induced a slight upregulation of IL-6 in LNE
(1.52pg/mL)andONE(1.68pg/mL),whereasIL-6levelsfur-
ther decreased in LE (0.44pg/mL). These changes were not
signiﬁcant (Table 1). The median diﬀerence before and after
training was signiﬁcantly diﬀerent between the three groups
(P = .048). This eﬀect was mainly seen between LE and LNE
(−0.12pg/ml versus +11pg/ml, P = .013, supplementary
Table III available on line at doi: 10.1155/2011/308965).
TNF-α is a cytokine and mediator of systemic inﬂamma-
tion. It is involved in acute phase reactions. LE showed the
lowest TNF-α levels (0.55pg/mL) at baseline, with the high-
est levels being detected in ONE (1.62pg/mL) and in LNE
(1.19pg/mL). Exercise training generated a downregulation
ofTNF-αserumlevelsinallgroups(LE:downto0.22pg/mL;
ONE: down to 1.12pg/mL and LNE: down to 0.77pg/mL),
withoutreachingstatisticalsigniﬁcance(Table1).Therewere
no signiﬁcantly diﬀerent eﬀects among the three groups
(P = .821, supplementary Table III available on line at doi:
10.1155/2011/308965).
4. Discussion
Exercise and obesity have been shown to modify the immune
system [1, 12]. In this paper we focused on the eﬀect of
regular aerobic exercise on markers of the innate immune-
response [26]. All subjects, including the obese athletes,
were pretrained, and so these obese individuals are not
representative for the majority of obese subjects.Mediators of Inﬂammation 7
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Figure 2: Expression of TLR-2 (a), TLR-4 (b), and TLR-7 (c) by analysis of mRNA levels via RT-PCR. Training-induced changes were
analyzed using the delta-delta ct method. Expression of MyD88 (d), TLR-2 (e), TLR-4 (f), and TLR-7 (g) by analyses of protein expression
(Western blot of 4 representative examples of the LNE-group). Densitometry analysis (h) found a signiﬁcant increased expression for TLR-4
and TLR-7. For MyD88 and TLR-2, no signiﬁcant changes were found. Statistical analysis of the diﬀerent time-points (intra group-analysis)
was performed using the Wilcoxon-Test; the comparison of the diﬀerent groups with each other (inter group analysis) was done by using the
Mann-Whitney U Test (∗∗P<. 01; ∗P<. 05; n = 15/16/16 for PCR and n = 8 for Western blot).
We were able to demonstrate a diﬀerence in the
expression of the BDCA-1 and -2 fractions in lean and
obese subjects and, for the ﬁrst time, illustrate the eﬀect of
exercise on dendritic cell subpopulations and TLR-2/-4, and
-7 expressions.
In obese subjects, exercise induced an upregulation of
BDCA-1+cells,whereasBDCA-2+cellsweredownregulated.
We further found an increased gene and protein expression
ofTLR-4andTLR-7independentofthebodycompositionof
theathletes.Withrespecttothesignalingpathway,wedidnot
ﬁnd proof of an activation of the TLR pathway, since MyD88
gene activation and protein expression remained unchanged
during training. This is supported by the fact that the NF-kB
transcription faction mRNA was not upregulated over time.
There is evidence that lower levels of circulating BDCA-
1 DCs in obese subjects are associated with obesity-induced8 Mediators of Inﬂammation
dyslipidemia [27]. Dyslipidemia is not restricted to the rou-
tinely quantiﬁed lipids such as LDL, HDL, and triglyceride
but enfolds biomarkers such as adiponectin and oxLDL [28].
Robertson et al. demonstrate a distinct [29] Th-2-based
autoimmune response to the autoantigen malondialdehyde-
LDL [30], providing evidence for dyslipidemia inﬂuenc-
ing the immune response. Furthermore, previous studies
have shown that dyslipidemia may impair antiviral, and
antibacterial responses [31–34] which may, in part, explain
the increased cardiovascular risk and mortality in obese
individuals[8].However,themechanismshaveyettobefully
identiﬁed. It remains unclear whether dyslipidemia leads
to an overall immunosuppression or whether it modulates
speciﬁc immune pathways.
In previous studies, Th-1-induced activation of DCs was
considerably impaired upon oxLDL treatment, whereas Th-
2-induced development was enhanced [31–34]. In our study,
obese subjects showed high oxLDL levels accompanied by
the lowest BDCA-1 expressing cells. During training, oxLDL
decreased whereas BDCA-1 positive cells increased. Fuchs
et al. described a reduction of BDCA-1 levels in patients
with cerebral infarction, which was associated with higher
infection rates. When analyzing previous data with respect
to BDCA-1 expression, an increase of BDCA-1 expression
seems to coincide with a higher antiviral, antibacterial and
antitumor activity [35–37].
Otheranimalstudiessupportthebeneﬁcialeﬀectofexer-
cise on dendritic cells by demonstrating an enhanced activity
of DCs against tumor and pathogen-eliminating cells [38–
40]. There is also evidence that demonstrates an association
between decreased DCs and the progression of coronary
arterydisease[41].Theexercise-inducedreductionofoxLDL
levels in obese participants, as presented in our study, might
diminish the susceptibility of low-density lipoprotein to
oxidationwhichinturnmaypreventendothelialdysfunction
and reduce inﬂammation [42, 43]. This does not, however,
explain the increase in oxLDL seen in LE, which did not
correlate with changes in BDCA-1/-2 expression. Further
aspectsseemtoinﬂuencethisimmunologicalrelation.LEare
characterized by very high training intensities and duration
which might cause high levels of oxidative stress leading to
an upregulation of oxLDL.
In addition to the changes in immune cell subpopu-
lations, we were also able to detect eﬀects related to the
expression of TLRs. TLR-2 is responsible for the detection
of gram-positive bacteria, TLR-4 for gram-negative bacteria,
and TLR-7 has a high detection potential for ssRNA (e.g.,
inﬂuenza virus) [19]. Besides anti-inﬂammatory eﬀects,
TLR-4 and -7 upregulation induce antitumor activity
[44].
The exercise program induced an upregulation of the
gene and protein expression of TLR-4 and TLR-7. These
could be interpreted as an increased immune responsiveness
and would point out the strenuous nature of our training
regimen.
To date, there are only a handful of studies that analyze
the eﬀect of exercise on TLRs. Stewart and Flynn et al.
described an exercise-induced decrease of TLR-4 on CD14
positive cells [45, 46]. The discrepancy to our ﬁndings can
be explained by the fact that we analyzed total PBMCs,
whereas the above working group looked at CD14+ cells
only. Looking at CD14 cells primarily does not take into
account that TLRs are also expressed on B-,T-cells and
naturally on DCs [47].
The upregulation of TLRs may be accompanied by
an increased expression of sentinel receptors. This may
implicate a potentially higher capacity in the ﬁrst line
response to a potential pathogen. The TLR modiﬁcations
cannot be validated as an increased inﬂammatory response,
since systemic cytokines were stable or even decreased after
the training program. Furthermore, the lack of MyD88 and
NF-kB upregulation implicates that the TLR activation is not
induced by an inﬂammatory stimulus.
In our study setting, exercise did not signiﬁcantly alter
classic mediators of inﬂammation. This is probably due to
the fact that the subjects in our study were already physically
trained before the start of the training program and showed
relatively low inﬂammatory markers at baseline, a condition
that has been previously described [48]. Main diﬀerences
were seen in ONE compared to LE. A main discrepancy
between these two groups is the waist circumference, which
correlates well with the total body fat burden. There is also
a correlation between fat-tissue-mass and hormone activity.
oxLDL and adiponectin levels diﬀered in ONE and LE at
baseline. Exercise training reduced waist circumference and
oxLDL levels in ONE, which was associated with increased
adiponectin levels. Statistical diﬀerences between ONE and
LNE could not be detected.
5. Conclusions
Exercise-induced immunomodulation such as changes in
BDCA-1 and -2 and TLR expression in obese subjects seems
to be consistent with a reduction of total body fat and dys-
lipidemia. We describe new immunomodulatory ﬁndings by
whichregularaerobicexercisemodulatestheimmunesystem
response, increases inﬂammatory resistance, and mediates
cardiovascular protection in obesity. Future studies are
necessary to determine to what extend these immunomod-
ulatory eﬀects inﬂuence the cardiovascular system.
6. Limitations
As in most studies involved in exercise intervention, study
group size is limited. 13 subjects dropped out during the
exercise period. All participants prepared to run a marathon
at the end of the 10-week training program. All subjects,
including the obese athletes, were pretrained, and so we did
not include the sedentary obese population. However, from
what is currently known in exercise immunology, one may
speculate that the eﬀect of the training intervention would
likely be more pronounced in sedentary obese subjects.
Professional exercise supervision was oﬀered throughout
the trial. Training intensity was high in all groups and was
adapted depending on individual training levels. Regular
day-to-day exercise with lower training intensity is likely to
show similar results in previously untrained obese subjects.
Larger studies including physically inactive obese individualsMediators of Inﬂammation 9
undergoing less sophisticated training protocols are neces-
sary to determine achievable results. Moreover, to achieve
moremechanisticalinsightfuturestudiesshouldincorporate
immunomodulatory eﬀects of exercise on microvascular
function in particular.
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